Nanomedicine: Nanotechnology, Biology and Medicine
Volume 5, Issue 1 , Pages 8-20, March 2009

Drug delivery of siRNA therapeutics: potentials and limits of nanosystems

  • Daniela Reischl, MS
  • ,
  • Andreas Zimmer, PhD

      Affiliations

    • Corresponding Author InformationCorresponding author. Institute of Pharmaceutical Sciences, Department of Pharmaceutical Technology, Karl-Franzens-University, Schubertstrasse 6, 8010 Graz, Austria.

Institute of Pharmaceutical Sciences, Department of Pharmaceutical Technology, Karl-Franzens-University, Graz, Austria

Received 18 February 2008; accepted 4 June 2008. published online 22 July 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 10.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 No conflict of interest was reported by the authors of this article.

PII: S1549-9634(08)00082-8

doi:10.1016/j.nano.2008.06.001

Nanomedicine: Nanotechnology, Biology and Medicine
Volume 5, Issue 1 , Pages 8-20, March 2009